keyword
https://read.qxmd.com/read/38593195/childhood-vaccination-coverage-and-regional-differences-in-swiss-birth-cohorts-2012-2021-are-we-on-track
#21
JOURNAL ARTICLE
Simeon J Zürcher, Andri Signorell, Anja Léchot-Huser, Christoph Aebi, Carola A Huber
AIMS: Many western countries are challenged by delayed and insufficient vaccination coverage rates in children, and thus missing WHO coverage targets. This study aimed to estimate vaccination coverage and timeliness in Swiss children over a decade. Furthermore, we evaluated the impact of COVID-19, regional variations, and the adherence to the amended vaccination schedule in 2019. METHODS: Retrospective observational study with Swiss health insurance claims data including birth cohorts 2012-2021 of children continuously observed until ages 13, 25, and 48 months respectively...
November 22, 2023: Vaccine
https://read.qxmd.com/read/38591901/-expression-of-immune-checkpoints-pd-l1-ctla4-lag3-in-the-microenvironment-of-colon-adenocarcinoma-depending-on-mmr-status
#22
JOURNAL ARTICLE
S S Naumov, N V Krakhmal, L A Tashireva, S V Vtorushin
OBJECTIVE: Study of the features of expression of immune checkpoint proteins PD-L1, CTLA4 and LAG3 in the microenvironment of colon adenocarcinoma depending on MMR status. MATERIAL AND METHODS: The study group consisted of 32 patients with a morphologically confirmed diagnosis of colon cancer; all of them underwent surgical treatment in the form of hemicolonectomy or resection. The work assessed samples of tumor tissue obtained as a result of surgery, the study was carried out in 3 stages: morphological examination of histological slides of colon tumors at the light-optical level, immunohistochemistry examination of tumor samples to determine the dMMR/pMMR status of carcinoma using a panel of antibodies to proteins of the unpaired nucleotide repair system MLH1, MSH2, MSH6 and PMS2, multiplex analysis of PD-L1, CTLA4, LAG3, CD3+, CD8+, CD163+ markers using the Vectra 3...
2024: Arkhiv Patologii
https://read.qxmd.com/read/38591430/combination-of-dasatinib-and-venetoclax-in-newly-diagnosed-chronic-phase-chronic-myeloid-leukemia
#23
JOURNAL ARTICLE
Elias Jabbour, Fadi G Haddad, Koji Sasaki, Bing Z Carter, Yesid Alvarado, Cedric Nasnas, Lewis Nasr, Lucia Masarova, Naval Daver, Naveen Pemmaraju, Nicholas J Short, Jeffrey Skinner, Tapan Kadia, Gautam Borthakur, Guillermo Garcia-Manero, Farhad Ravandi, Ghayas C Issa, Michael Andreeff, Hagop Kantarjian
BACKGROUND: The dual inhibition of the BCR::ABL1 tyrosine kinase and BCL-2 could potentially deepen the response rates of chronic myeloid leukemia in chronic phase (CML-CP). This study evaluated the safety and efficacy of the combination of dasatinib and venetoclax. METHODS: In this phase 2 trial, patients with CML-CP or accelerated phase (clonal evolution) received dasatinib 50 mg/day for three courses; venetoclax was added in course 4 for 3 years. The initial venetoclax dose was 200 mg/day continuously but reduced later to 200 mg/day for 14 days, and to 100 mg/day for 7 days per course once a molecular response (MR)4...
April 9, 2024: Cancer
https://read.qxmd.com/read/38590982/comparison-of-microsatellite-instability-with-clinicopathologic-data-in-patients-with-colon-adenocarcinoma
#24
JOURNAL ARTICLE
Emine Cesmecioglu Karavin, Zeynep Sağnak Yılmaz, Hilmi Yazici, Safak Ersoz, Sevdegul Mungan
Background Microsatellite instability (MSI) is a genetic condition caused by errors in DNA repair genes that cause colorectal cancer (CRC). The literature contradicts the frequency of MSI in sporadic CRCs and its effect on prognosis. This study investigated the distribution of clinicopathologic features and the relationship between MSI and survival outcomes. Methodology This is a retrospective study of 101 consecutive cases of CRC and immunohistochemical studies. All cases were retrospectively reviewed and reevaluated by histological grade, lymphovascular invasion, perineural invasion, tumor borders, dirty necrosis, tumor-infiltrating lymphocytes (TILs), Crohn's-like lymphoid reaction, mucinous and medullary differentiation, and tumoral budding from pathological slides...
April 2024: Curēus
https://read.qxmd.com/read/38588886/gastric-carcinoma-in-autoimmune-gastritis-a-histopathologic-and-molecular-study
#25
JOURNAL ARTICLE
Valentina Angerilli, Alessandro Vanoli, Giulia Celin, Carlotta Ceccon, Jessica Gasparello, Marianna Sabbadin, Giuseppe De Lisi, Michele Paudice, Marco Vincenzo Lenti, Laura Rovedatti, Antonio Di Sabatino, Francesca Bazzocchi, Sara Lonardi, Edoardo Savarino, Claudio Luchini, Paola Parente, Federica Grillo, Luca Mastracci, Matteo Fassan
Patients with autoimmune gastritis (AIG) have a 13-fold risk of developing type-1 neuroendocrine tumors, whereas the risk for gastric adenocarcinoma is still uncertain. Here we describe the clinicopathological and molecular features of a series of gastric carcinomas (GC) arising in the context of AIG. A total of 26 AIG-associated GC specimens were collected from four Italian Institutions. Immunohistochemistry for MUC1, MUC2, MUC5AC, MUC6, CDX2, HER2, PD-L1, CLDN18, Mismatch Repair (MMR) proteins, and p53 and EBER in situ hybridization were performed...
April 6, 2024: Modern Pathology
https://read.qxmd.com/read/38588883/somatic-tumor-testing-in-prostate-cancer-experience-of-a-tertiary-care-center-including-pathologist-driven-reflex-testing-of-localized-tumors-at-diagnosis
#26
JOURNAL ARTICLE
Susan Prendeville, Harpreet Kaur, Shervin Ansari, Shifaa Alqaqa, Tracy L Stockley, Katherine Lajkosz, Theodorus van der Kwast, Carol C Cheung, Shamini Selvarajah
Somatic tumor testing in prostate cancer (PCa) can guide treatment options by identifying clinically actionable variants in DNA damage repair (DDR) genes, including acquired variants not detected by germline testing alone. Guidelines currently recommend performing somatic tumor testing in metastatic PCa, while there is no consensus on the role of testing in regional disease and the optimal testing strategy is involving. This study evaluates the frequency, distribution, and pathologic correlates of somatic DDR mutations in metastatic and localized PCa following the implementation of pathologist-driven reflex testing at diagnosis...
April 6, 2024: Modern Pathology
https://read.qxmd.com/read/38587317/novel-wrn-helicase-inhibitors-selectively-target-microsatellite-unstable-cancer-cells
#27
JOURNAL ARTICLE
Gabriele Picco, Yanhua Rao, Angham Al Saedi, Yang Lee, Sara F Vieira, Shriram Bhosle, Kieron May, Carmen Herranz-Ors, Samantha J Walker, Raynold Shenje, Cansu Dincer, Freddy Gibson, Ruby Banerjee, Zoe Hewitson, Thilo Werner, Joshua E Cottom, Yang Peng, Nanhua Deng, Philip Landis, Daniela Conticelli, Katrina McCarten, Jacob Bush, Mamta Sharma, Howard Lightfoot, David House, Emma Milford, Emma K Grant, Michal P Glogowski, Craig D Wagner, Marcus Bantscheff, Anna Rutkowska-Klute, Cell Model Network Uk Group, Francesca Zappacosta, Jonathan Pettinger, Syd Barthorpe, H Christian Eberl, Brian T Jones, Jessica L Schneck, Dennis J Murphy, Emile E Voest, Joshua P Taygerly, Michael P DeMartino, Matthew A Coelho, Jonathan Houseley, Geeta Sharma, Benjamin J Schwartz, Mathew J Garnett
Microsatellite-unstable (MSI) cancers require WRN helicase to resolve replication stress due to expanded DNA (TA)n-dinucleotide repeats. WRN is a promising synthetic lethal target for MSI tumours, and WRN inhibitors are in development. Here, we used CRISPR-Cas9 base editing to map WRN residues critical for MSI cells, validating the helicase domain as the primary drug target. Fragment-based screening led to the development of potent and highly selective WRN helicase covalent inhibitors. These compounds selectively suppressed MSI model growth In vitro and In vivo by mimicking WRN loss, inducing DNA double-strand breaks at expanded TA-repeats and DNA damage...
April 9, 2024: Cancer Discovery
https://read.qxmd.com/read/38587087/rainbow-trout-oncorhynchus-mykiss-walbaum-1792-adenocarcinoma-investigation-with-various-diagnostic-imaging-techniques
#28
JOURNAL ARTICLE
Márton Hoitsy, György Hoitsy, János Gál, Árisz Ziszisz, Tamás Tóth, Endre Sós, Viktória Sós-Koroknai, Csaba Jakab, Örs Petneházy, Tamás Donkó, Tamás Molnár, Miklós Marosán
Diagnostic imaging techniques provide a new aspect of the ante-mortem and post-mortem diagnostics in fish medicine. Ultrasonography, computed tomography (CT) and magnetic resonance imaging (MRI) can provide more information about the internal organs and pathognomic lesions. The authors used diagnostic imaging techniques to evaluate and describe the neoplastic malformation in a 3-year-old female rainbow trout (Oncorhynchus mykiss). The fish was examined with Siemens Somatom Definition AS + CT scanner and Siemens Biograph mMR scanner...
April 8, 2024: Journal of Fish Diseases
https://read.qxmd.com/read/38585716/de-novo-antibody-discovery-in-human-blood-from-full-length-single-b-cell-transcriptomics-and-matching-haplotyped-resolved-germline-assemblies
#29
John Beaulaurier, Lynn Ly, J Andrew Duty, Carly Tyer, Christian Stevens, Chuan-Tien Hung, Akash Sookdeo, Alex W Drong, Shreyas Kowdle, Daniel J Turner, Sissel Juul, Scott Hickey, Benhur Lee
Immunoglobulin (IGH, IGK, IGL) loci in the human genome are highly polymorphic regions that encode the building blocks of the light and heavy chain IG proteins that dimerize to form antibodies. The processes of V(D)J recombination and somatic hypermutation in B cells are responsible for creating an enormous reservoir of highly specific antibodies capable of binding a vast array of possible antigens. However, the antibody repertoire is fundamentally limited by the set of variable (V), diversity (D), and joining (J) alleles present in the germline IG loci...
March 29, 2024: bioRxiv
https://read.qxmd.com/read/38585381/an-ecological-analysis-of-socio-economic-determinants-associated-with-paediatric-vaccination-coverage-in-the-campania-region-a-population-based-study-years-2003-2017
#30
JOURNAL ARTICLE
Michelangelo Mercogliano, Ronan Lemwel Valdecantos, Gianluca Fevola, Michele Sorrentino, Gaetano Buonocore, Maria Triassi, Raffaele Palladino
INTRODUCTION: Vaccines are the most cost-effective and straightforward intervention against severe infectious diseases. However, in Europe and in Italy, paediatric vaccination coverage for certain vaccines remains suboptimal, with considerable regional differences in Italy. Vaccine coverage varies significantly due to socio-economic and organisational factors. Aim of this study was to assess the influence of the Deprivation Index, the density of General Practitioners and General Paediatricians per inhabitants on the coverage of both mandatory and non-mandatory paediatric vaccinations across local health authorities and health districts in the Campania Region for birth cohorts from 2001 to 2015...
June 2024: Vaccine: X
https://read.qxmd.com/read/38585192/systematic-review-of-intralesional-therapies-for-cutaneous-warts
#31
REVIEW
Sarah A Mullen, Emma L Myers, Rebecca L Brenner, Kim T Nguyen, Tara A Harper, Darby Welsh, Storm Keffer, Jenna Mueller, Melodi Javid Whitley
Intralesional therapies are used for recalcitrant warts, but no Food and Drug Administration-approved treatment exists nor is there consensus regarding the most efficacious therapy. Therefore, this systematic review aims to summarize efficacy and adverse events reported in 62 randomized controlled trials (RCTs) of intralesional therapies for cutaneous warts. The most studied intralesional therapies included measles, mumps, rubella (MMR) vaccine (n = 24 studies), purified protein derivative (PPD) (n = 19 studies), vitamin D3 (n = 15 studies), and Candida antigen (n = 14 studies)...
May 2024: JID innovations
https://read.qxmd.com/read/38584802/germline-mlh1-and-msh6-mutations-from-two-lynch-syndrome-families-identified-in-a-patient-with-early-onset-of-endometrial-cancer-a-case-report
#32
Yi-Ching Huang, Peng-Chan Lin, Pei-Ying Wu, Nai-Syuan Chen, Meng-Ru Shen, Yu-Min Yeh, Ya-Min Cheng
INTRODUCTION: Lynch syndrome is caused by a germline mutation in mismatch repair (MMR) genes, leading to the loss of expression of MMR heterodimers, either MLH1/PMS2 or MSH2/MSH6, or isolated loss of PMS2 or MSH6. Concurrent loss of both heterodimers is uncommon, and patients carrying pathogenic variants affecting different MMR genes are rare, leading to the lack of cancer screening recommendation for these patients.Case presentation:Here, we reported a female with a family history of Lynch syndrome with MLH1 c...
June 2024: Gynecologic Oncology Reports
https://read.qxmd.com/read/38584561/erh-impacts-patient-prognosis-and-tumor-immune-microenvironment-a-pan-cancer-analysis
#33
JOURNAL ARTICLE
Qianhui Gong, Qiong Li, Xiaobing Shen, Zhichao Xu
BACKGROUND: The enhancer of rudimentary homolog (ERH) has been shown to play significant roles in tumorigenesis and progression. However, few systematic pan-cancer analyses about ERH have been described. METHODS: From the tumor immune estimation resource web server2.0 (TIMER2.0), the Genotype-Tissue Expression database (GTEx) and the Gene Expression Profile Interactive Analysis version 2 (GEPIA2) databases, we explored the expression profiles and prognostic significance of ERH in 33 cancers...
April 4, 2024: Combinatorial Chemistry & High Throughput Screening
https://read.qxmd.com/read/38582692/vaccine-coverage-among-children-born-to-immigrant-parents-in-norway-2000-2020
#34
JOURNAL ARTICLE
Rebecca Nybru Gleditsch, Trine Skogset Ofitserova, Richard Aubrey White, Marte Karoline Råberg Kjøllesdal, Evy Dvergsdal, Bo T Hansen, Brita Askeland Winje
BACKGROUND: The Norwegian Childhood Immunization Program maintains a high national coverage of 95-97% in the most recent years. Whether there are subgroups with lower uptake is less studied. This study examines pertussis and measles vaccination coverage among six immigrant groups in Norway. These vaccines are normally administered as part of different combination vaccines and their coverage rate indicate the national vaccination coverage against a range of additional infections. METHODS: Data from the Norwegian National Population Register were linked at individual level with vaccination data from the Norwegian Immunisation Registry...
April 5, 2024: Vaccine
https://read.qxmd.com/read/38577946/-retracted-microrna%C3%A2-25-protects-nucleus-pulposus-cells-against-apoptosis-via-targeting-sumo2-in-intervertebral-disc-degeneration
#35
Changbin Lei, Jian Li, Guang Tang, Jiong Wang
Following the publication of this paper, the authors requested that the paper be retracted, specifically on account of deficiencies that were identified both in the documentation of patient records and in written consent pertaining to the data presented in Fig. 1. After having considered the authors' request, the Editor of Molecular Medicine Reports has agreed that this paper should be retracted from the Journal. All the authors are in agreement with the decision to retract this paper. The Editor apologizes to the readership for any inconvenience caused...
June 2024: Molecular Medicine Reports
https://read.qxmd.com/read/38577942/-corrigendum-long-non%C3%A2-coding-rna-neat1-promotes-ovarian-cancer-cell-invasion-and-migration-by-interacting-with-mir%C3%A2-1321-and-regulating-tight-junction-protein-3-expression
#36
Min Luo, Lei Zhang, Hongying Yang, Kaili Luo, Chen Qing
Subsequently to the publication of the above article, an interested reader drew to the authors' attention that, for the cell invasion and migration assay images shown for the A2780 cell line in Figs. 1 and Fig. 3 on p. 3433 and 3435 respectively, the same data panel had apparently been selected to show the results of the si‑NEAT1 experiment in Fig. 1 and the si‑TJP3 experiment in Fig. 3. After having re‑examined their original data, the authors have realized that the image correctly shown for Fig...
June 2024: Molecular Medicine Reports
https://read.qxmd.com/read/38577934/research-progress-on-oncoprotein-hepatitis-b-x%C3%A2-interacting-protein-review
#37
JOURNAL ARTICLE
Lei Cheng, Lijuan Guo, Teng Zou, Yisong Yang, Ran Tao, Shuangping Liu
Hepatitis B X‑interacting protein (HBXIP) is a membrane protein located on the lysosomal surface and encoded by the Lamtor gene. It is expressed by a wide range of tumor types, including breast cancer, esophageal squamous cell carcinoma and hepatocellular carcinoma, and its expression is associated with certain clinicopathological characteristics. In the past decade, research on the oncogenic mechanisms of HBXIP has increased and the function of HBXIP in normal cells has been gradually elucidated. In the present review, the following was discussed: The normal physiological role of the HBXIP carcinogenic mechanism; the clinical significance of high levels of HBXIP expression in different tumors; HBXIP regulation of transcription, post‑transcription and post‑translation processes in tumors; the role of HBXIP in improving the antioxidant capacity of tumor cells; the inhibition of ferroptosis of tumor cells and regulating the metabolic reprogramming of tumor cells; and the role of HBXIP in promoting the malignant progression of tumors...
June 2024: Molecular Medicine Reports
https://read.qxmd.com/read/38577930/long-non%C3%A2-coding-rna-dancr-aggravates-breast-cancer-through-the-mir%C3%A2-34c-e2f1-feedback-loop
#38
JOURNAL ARTICLE
Shuai Yan, Lizhi Teng, Juntong Du, Liang Ji, Peng Xu, Wenxi Zhao, Weiyang Tao
Emerging scientific evidence has suggested that the long non‑coding (lnc)RNA differentiation antagonizing non‑protein coding RNA ( DANCR ) serves a significant role in human tumorigenesis and cancer progression; however, the precise mechanism of its function in breast cancer remains to be fully understood. Therefore, the objective of the present study was to manipulate DANCR expression in MCF7 and MDA‑MB‑231 cells using lentiviral vectors to knock down or overexpress DANCR . This manipulation, alongside the analysis of bioinformatics data, was performed to investigate the potential mechanism underlying the role of DANCR in cancer...
June 2024: Molecular Medicine Reports
https://read.qxmd.com/read/38577929/induction-of-the-human-cdc45-gene-promoter-activity-by-natural-compound-trans-%C3%A2-resveratrol
#39
JOURNAL ARTICLE
Jun Arakawa, Hikaru Kondoh, Tokiyoshi Matsushita, Yoko Ogino, Masashi Asai, Sei-Ichi Tanuma, Fumiaki Uchiumi
GGAA motifs in the human TP53 and HELB gene promoters play a part in responding to trans ‑resveratrol (Rsv) in HeLa S3 cells. This sequence is also present in the 5'‑upstream region of the human CDC45 gene, which encodes a component of CMG DNA helicase protein complex. The cells were treated with Rsv (20 µM), then transcripts and the translated protein were analyzed by quantitative RT‑PCR and western blotting, respectively. The results showed that the CDC45 gene and protein expression levels were induced after the treatment...
June 2024: Molecular Medicine Reports
https://read.qxmd.com/read/38577927/octreotide-attenuates-intestinal-barrier-damage-by-maintaining-basal-autophagy-in-caco2-cells
#40
JOURNAL ARTICLE
Xiaoli Liu, Yan Zhou, Yu Zhang, Xigang Cui, Donglin Yang, Yuling Li
The intestinal mucosal barrier is of great importance for maintaining the stability of the internal environment, which is closely related to the occurrence and development of intestinal inflammation. Octreotide (OCT) has potential applicable clinical value for treating intestinal injury according to previous studies, but the underlying molecular mechanisms have remained elusive. This article is based on a cell model of inflammation induced by lipopolysaccharide (LPS), aiming to explore the effects of OCT in protecting intestinal mucosal barrier function...
June 2024: Molecular Medicine Reports
keyword
keyword
11424
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.